Hologic is a U.S.-based IVD and medical device company with revenues of approximately $2.5 billion in diagnostics in 2025, specializing in women's health, molecular diagnostics, and surgical products. Hologic's Panther and Panther Fusion platforms are market leaders in women's health molecular testing — cervical cancer screening (HPV and Pap), STI testing (chlamydia, gonorrhea, trichomonas), and reproductive health diagnostics. The company holds a leading position in blood screening through its TMA molecular technology. Hologic's diagnostics business benefits from a large, captive installed base of Panther instruments globally, with recurring reagent revenue providing strong aftermarket economics.
This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.
Topics Covered
• Strategic Directions — Panther Menu Expansion, Women's Health Leadership, and Blood Screening Through 2030
• Financial Performance — Revenue, Revenue by Segment, Revenue by Geography, EBITDA, and R&D 2023-2025
• SWOT Analysis — Competitive Advantages, Structural Vulnerabilities, Opportunities, and Risks
• Technological Know-How — Panther, Panther Fusion, TMA Technology, and IP Portfolio
• Latest Products and Services — New Assays, Menu Expansions, and Innovation Pipeline
• M&A — Acquisitions, Divestitures, and Partnerships 2023-2025
• Marketing Tactics — Women's Health Laboratory Strategy and GPO Positioning
• Organization and Management — Leadership, Structure, and Workforce
Table of Contents
1. Executive Summary
2. Strategic Directions
3. Financial Performance
4. SWOT Analysis
5. Technological Know-How
6. Latest Products and Services
7. M&A
8. Marketing Tactics
9. Organization and Management
10. Appendix
List of Tables
Table 1. Hologic — Key Financial Metrics Summary 2023-2025
Table 2. Hologic — Revenue by Segment 2023-2025
Table 3. Hologic — Revenue by Geography 2023-2025
Table 4. Hologic — R&D Investment 2023-2025
Table 5. Hologic — SWOT Analysis
Table 6. Hologic — Core Technology Capabilities and Key Platforms
Table 7. Hologic — Key Analyzers and Reagent Portfolio
Table 8. Hologic — M&A Activity Summary 2023-2025
Table 9. Hologic — Key Management and Leadership
Table 10. Hologic — Strategic Priorities 2025-2030
